Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

146 results about "Radiomics" patented technology

In the field of medicine, radiomics is a method that extracts large amount of features from radiographic medical images using data-characterisation algorithms. These features, termed radiomic features, have the potential to uncover disease characteristics that fail to be appreciated by the naked eye. The hypothesis of radiomics is that the distinctive imaging features between disease forms may be useful for predicting prognosis and therapeutic response for various conditions, thus providing valuable information for personalized therapy. Radiomics emerged from the medical field of oncology and is the most advanced in applications within that field. However, the technique can be applied to any medical study where a disease or a condition can be imaged.

Multi-modal, multi-resolution deep learning neural networks for segmentation, outcomes prediction and longitudinal response monitoring to immunotherapy and radiotherapy

Systems and methods for multi-modal, multi-resolution deep learning neural networks for segmentation, outcomes prediction and longitudinal response monitoring to immunotherapy and radiotherapy are detailed herein. A structure-specific Generational Adversarial Network (SSGAN) is used to synthesize realistic and structure-preserving images not produced using state-of-the art GANs and simultaneously incorporate constraints to produce synthetic images. A deeply supervised, Multi-modality, Multi-Resolution Residual Networks (DeepMMRRN) for tumor and organs-at-risk (OAR) segmentation may be used for tumor and OAR segmentation. The DeepMMRRN may combine multiple modalities for tumor and OAR segmentation. Accurate segmentation is may be realized by maximizing network capacity by simultaneously using features at multiple scales and resolutions and feature selection through deep supervision. DeepMMRRN Radiomics may be used for predicting and longitudinal monitoring response to immunotherapy. Auto-segmentations may be combined with radiomics analysis for predicting response prior to treatment initiation. Quantification of entire tumor burden may be used for automatic response assessment.
Owner:MEMORIAL SLOAN KETTERING CANCER CENT

Auxiliary assessment method for prognosis of nasopharynx cancer based on enhanced MRI radiomics

The invention relates to an auxiliary assessment method for prognosis of nasopharynx cancer based on enhanced MRI radiomics. The auxiliary assessment method comprises the steps of: (1), performing MRIimage processing; (2), extracting imaging features; (3), screening the imaging features; (4), establishing a radiomics scoring formula; (5), screening clinical risk factors; and (6), establishing a prognostic survival model: establishing a prognostic observation model through combination of a radiomics score and the clinical risk factors of a patient with nasopharynx cancer, performing qualitative and quantitative prediction on the PFS (progression free survival) of the patient, and furthermore, assessing the performance of the prognostic survival model. The auxiliary assessment method in theinvention has little harm to the image examination of the patient; qualitative and quantitative analysis on the survival time of a specific patient is carried out; therefore, a doctor is assisted tomake an individualized treatment and follow-up visit scheme; furthermore, the doctor is assisted to assess the survival and recurrence time of the patient; simultaneously, the performance of the obtained prognostic survival model is verified; and thus, the accuracy of a prognostic prediction model is ensured.
Owner:XIANGYA HOSPITAL CENT SOUTH UNIV

NSCLC patient postoperative short-period recurrence metastasis risk evaluating system

The invention provides an NSCLC patient postoperative short-period recurrence metastasis risk evaluating system which comprises a preprocessing module, a characteristic extracting module, an AI network cluster risk evaluating module and an ANFIS network integrated risk evaluating module. The preprocessing module is used for collecting and preprocessing multidimensional patient clinical data. The multidimensional patient clinical data comprise patient preoperative CT radiomics data, tumor histopathology data and tumor clinical. The characteristic extracting module is used for extracting the characteristic of the data sample after preprocessing. The AI network cluster risk evaluating module is used for performing recurrence risk probability evaluation on the extracted sample characteristic.The ANFIS network integrated risk evaluating module is used for using a recurrence risk probability evaluation result as an input characteristic vector, establishes an ANFIS network, uses a recurrence/metastasis risk quantification probability and dangerous degree as the output, and performs final integrated risk evaluation. The system can supply a reference for selecting a radial curing postoperative comprehensive treatment plan by a lung cancer patient and has high predicting accuracy.
Owner:HANGZHOU DIANZI UNIV

Multi-modal, multi-resolution deep learning neural networks for segmentation, outcomes prediction and longitudinal response monitoring to immunotherapy and radiotherapy

Systems and methods for multi-modal, multi-resolution deep learning neural networks for segmentation, outcomes prediction and longitudinal response monitoring to immunotherapy and radiotherapy are detailed herein. A structure-specific Generational Adversarial Network (SSGAN) is used to synthesize realistic and structure-preserving images not produced using state-of-the art GANs and simultaneously incorporate constraints to produce synthetic images. A deeply supervised, Multi-modality, Multi-Resolution Residual Networks (DeepMMRRN) for tumor and organs-at-risk (OAR) segmentation may be used for tumor and OAR segmentation. The DeepMMRRN may combine multiple modalities for tumor and OAR segmentation. Accurate segmentation is may be realized by maximizing network capacity by simultaneously using features at multiple scales and resolutions and feature selection through deep supervision. DeepMMRRN Radiomics may be used for predicting and longitudinal monitoring response to immunotherapy. Auto-segmentations may be combined with radiomics analysis for predicting response prior to treatment initiation. Quantification of entire tumor burden may be used for automatic response assessment.
Owner:MEMORIAL SLOAN KETTERING CANCER CENT

Non-invasive liver epithelioid vascular smooth muscle lipoma image classification device based on radiomics

InactiveCN113269225AEfficient use ofImage enhancementImage analysisEpithelioid angiomyolipomaBlood vessel
The invention discloses a non-invasive liver epithelioid vascular smooth muscle lipoma image classification device based on radiomics, and belongs to the technical field of medical image processing. The non-invasive liver epithelioid vascular smooth muscle lipoma image classification device includes: a sampling module which for collecting CT/MRI images of liver epithelioid vascular smooth muscle lipoma, liver cancer and liver focal nodule hyperplasia meeting requirements; a focus area extraction module which is used for extracting a focus area; a feature extraction module which is used for carrying out radiomics feature extraction on the focus area; a feature screening module which is used for screening radiomics features; a random forest network training module which is used for training a random forest model to obtain a radiomics label; a clinical index fusion module which is used for fusing the radiomics prediction label and the clinical indexes of the patient and training a multivariate logistic regression model; and a classification module which is used for obtaining a final prediction label in combination with a random forest network and a multivariate logistic regression model so as to realize the classification of the liver epithelioid vascular smooth muscle lipoma images. The device is high in recognition precision, high in recognition speed, safe and stable.
Owner:ZHEJIANG UNIV

Machine learning-based bimodal image omics ground glass nodule classification method

The invention belongs to the technical field of medical treatment, and discloses a machine learning-based bimodal image omics ground glass nodule classification method, which comprises the following steps of: step 1, case data collection: collecting patients who receive 18F-FDG PET/CT examination due to suspicious ground glass nodules (GGN); step 2, image acquisition and reconstruction: performing image acquisition by adopting a PET/CT (positron emission tomography/computed tomography) imaging instrument; step 3, image feature extraction; and step 4, data processing and analysis. According to the method, the image omics model based on the combination of the PET image and the HRCT image is constructed by applying a machine learning method, the GGN is classified, including pre-infiltration lesion, micro-infiltration adenocarcinoma, infiltration adenocarcinoma and benign lesion, verification and testing, the method is good in robustness, high in accuracy, simple and feasible. According to the method, the functional metabolism information and the physical anatomical information of the molecular level of the focus are integrated, the prediction efficiency of traditional CT parameters and single CT radiomics is effectively improved, and clinical management of the GGN is facilitated.
Owner:THE FIRST PEOPLES HOSPITAL OF CHANGZHOU

Method for constructing lymph node metastasis prediction model of breast cancer patient based on radiomics

The invention discloses a method for constructing a lymph node metastasis prediction model of a breast cancer patient based on radiomics. The method comprises the following steps: acquiring magnetic resonance image data and clinical feature data of the patient; extracting image features based on the magnetic resonance image data; screening the image features by using a random forest algorithm to obtain a plurality of key image features, and establishing an image feature prediction model based on the key image features by using a support vector machine algorithm; performing single-factor analysis screening on the clinical feature data to obtain key clinical features, and establishing a clinical feature prediction model according to the key clinical features by adopting a support vector machine algorithm; and establishing a lymph node metastasis comprehensive prediction model according to the key image features and the key clinical features by adopting a support vector machine algorithm. According to the embodiment, the model is established by adopting the random forest algorithm and the support vector machine algorithm, the prediction model can be established based on the structure risk minimum principle, and the problem of over-learning can be avoided, so that the constructed prediction model is more stable and accurate.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

Esophageal varicosity classification system based on LightGBM and feature fusion

ActiveCN111881724AReduce complexityThe features are given equal weights, and the linear weighted fusion is used to give full play to them.Medical automated diagnosisRecognition of medical/anatomical patternsEsophageal varicesNuclear medicine
The invention discloses an esophageal varicosity classification system based on LightGBM and feature fusion. The esophageal varicosity classification system comprises a segmentation module for segmenting and extracting regions of interest of the liver, the spleen and the esophagus in a CT image; a feature extraction module performing radiomics feature extraction on the region-of-interest image ofeach part; a first weight distribution module distributing equal weights to the radiomics characteristics of each part to obtain a first characteristic matrix; a second weight distribution module judging the importance of each part to the varicose veins of the affected esophagus by adopting a LightGBM method according to the radiomics characteristics of each part, and performs weighted fusion on the radiomics characteristics of each part according to the importance to obtain a second characteristic matrix; a classification module training a LightGBM classification model for the first feature matrix and the second feature matrix, and classifies whether the to-be-detected CT image suffers from esophageal varicose veins. An esophageal varicosity classification model based on LightGBM and feature fusion is constructed on the basis of radiomics, the importance of each part is brought into play, and the classification performance is improved.
Owner:SHANDONG NORMAL UNIV

Vertebral body bone mineral density classification method based on image omics and deep learning feature fusion

The invention relates to the technical field of medical image segmentation and image classification, in particular to a centrum bone mineral density classification method based on radiomics and deep learning feature fusion, centrum under a CT image is divided into an osteoporosis group, a low bone mass group and a normal group, and the centrum bone mineral density classification method comprises the following steps: S1, establishing a centrum segmentation network based on CRF and attention guidance, and obtaining centrum cancellous bone masks L1 and L2; s2, deep learning feature extraction is performed on the feature map fused by the L1 and the L2 through GCAM-Net, and radiomics feature extraction is performed by using CT images and masks of the L1 and the L2; and S3, extracting an optimal feature set from the deep learning features by using a differential evolution algorithm, carrying out feature screening on the extracted radiomics features through an SVM-RFE method, finally carrying out feature fusion on the radiomics features and the deep learning features through a maximum correlation fusion algorithm, and carrying out classification by using a neural network. According to the technical scheme, deep learning features and radiomics features are combined, and the accuracy of bone mineral density classification is effectively improved.
Owner:NANTONG UNIVERSITY

Method for predicting biochemical recurrence risk after prostatic cancer radical operation by MRI (magnetic resonance imaging) image

InactiveCN114121225AAchieving Prognosis Prediction of Biochemical RecurrenceGuaranteed reliabilityMedical automated diagnosisMedical imagesRecurrence predictionProstatectomy radical
The invention relates to the technical field of computer medicine, and discloses a method for predicting a biochemical recurrence risk after a radical prostatic cancer operation through an MRI image, and the method comprises the following steps: S1, collection and arrangement of prostatic cancer cases: firstly, carrying out the retrospective collection and arrangement of MRI data and clinical data of at least 300 patients subjected to the radical prostatic cancer operation according to a group entering standard, wherein 200 patients are used for constructing a radiomics model, and 100 patients are used for verifying and optimizing the radiomics model; according to the method, a retrospective and prospective combined mode is innovatively adopted, the optimized image group student recurrence prediction model is constructed and verified on the basis of a large number of prostate cancer cases which are collected in the past and are subjected to standardized scanning, and the accuracy of the model is tested by using prostate cancer radical cases collected prospectively, so that the reliability of the model is ensured. Meanwhile, retrospective and prospective data are creatively applied in the research, and the stability and repeatability of image features are evaluated by adopting multiple methods.
Owner:冯朝燕
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products